{"podcast":{"title":"The Uromigos","slug":"the-uromigos-1214845","podcast_index_feed_id":1214845,"rss_url":"https://anchor.fm/s/13347ea8/podcast/rss","website_url":"https://www.uromigos.org","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/3122074/3122074-1626815623969-26c22e1d3574c.jpg","author":"The Uromigos","episode_count":479,"summary":"Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London","last_synced_at":"2026-07-13T22:19:20.611456+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845"},"episodes":[{"title":"Episode 513: Trials and Tribulations of Investigator-initiated Research","slug":"episode-513-trials-and-tribulations-of-investigator-initiated-research","published_at":"2026-07-13T10:57:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-513-trials-and-tribulations-of-investigator-initiated-research","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-513-Trials-and-Tribulations-of-Investigator-initiated-Research-e3lotpe","duration_seconds":1534,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-513-trials-and-tribulations-of-investigator-initiated-research/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-513-trials-and-tribulations-of-investigator-initiated-research.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 512: ENZA-P Nature Medicine translational data","slug":"episode-512-enza-p-nature-medicine-translational-data","published_at":"2026-07-06T06:00:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-512-enza-p-nature-medicine-translational-data","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-512-ENZA-P-Nature-Medicine-translational-data-e3l2vfa","duration_seconds":1872,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-512-enza-p-nature-medicine-translational-data/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-512-enza-p-nature-medicine-translational-data.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 510: ADCs in Prostate Cancer","slug":"episode-510-adcs-in-prostate-cancer","published_at":"2026-06-15T12:53:24+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-510-adcs-in-prostate-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-510-ADCs-in-Prostate-Cancer-e3kqflf","duration_seconds":1823,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-510-adcs-in-prostate-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-510-adcs-in-prostate-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 509: ASCO 2026 Review","slug":"episode-509-asco-2026-review","published_at":"2026-06-08T07:00:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-509-asco-2026-review","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-509-ASCO-2026-Review-e3kfc9g","duration_seconds":3312,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-509-asco-2026-review/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-509-asco-2026-review.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 508: ASCO 2026 Plenary - PROTEUS: ADT +/- Apalutamide in high-risk Localized Prostate Cancer","slug":"episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer","published_at":"2026-05-31T18:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-508-ASCO-2026-Plenary---PROTEUS-ADT---Apalutamide-in-high-risk-Localized-Prostate-Cancer-e3jja7d","duration_seconds":2380,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 507: ASCO 2026 - TALAPRO-3","slug":"episode-507-asco-2026-talapro-3","published_at":"2026-05-30T23:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-507-asco-2026-talapro-3","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-507-ASCO-2026---TALAPRO-3-e3jqvme","duration_seconds":2505,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-507-asco-2026-talapro-3/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-507-asco-2026-talapro-3.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 506: ASCO 2026 - How do we measure quality of life in GU patients?","slug":"episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients","published_at":"2026-05-30T19:22:29+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-506-ASCO-2026---How-do-we-measure-quality-of-life-in-GU-patients-e3k43nh","duration_seconds":1186,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 505 : ASCO 2026 - RAMPART","slug":"episode-505-asco-2026-rampart","published_at":"2026-05-30T15:00:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-505-asco-2026-rampart","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-505--ASCO-2026---RAMPART-e3jl61f","duration_seconds":1771,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-505-asco-2026-rampart/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-505-asco-2026-rampart.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer","slug":"episode-504-asco-2026-adc-drug-development-in-urothelial-cancer","published_at":"2026-05-29T22:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-504-asco-2026-adc-drug-development-in-urothelial-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-504-ASCO-2026---ADC-Drug-Development-in-Urothelial-Cancer-e3jsa4o","duration_seconds":2432,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-504-asco-2026-adc-drug-development-in-urothelial-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-504-asco-2026-adc-drug-development-in-urothelial-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 499: APCCC 2026 - Radioligands in Prostate Cancer","slug":"episode-499-apccc-2026-radioligands-in-prostate-cancer","published_at":"2026-05-25T14:43:37+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-499-apccc-2026-radioligands-in-prostate-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-499-APCCC-2026---Radioligands-in-Prostate-Cancer-e3jsav8","duration_seconds":2238,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-499-apccc-2026-radioligands-in-prostate-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-499-apccc-2026-radioligands-in-prostate-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 503: ASCO 2026 Preview","slug":"episode-503-asco-2026-preview","published_at":"2026-05-22T06:00:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-503-asco-2026-preview","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-503-ASCO-2026-Preview-e3jlmkg","duration_seconds":4930,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-503-asco-2026-preview/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-503-asco-2026-preview.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 502: AUA 2026 and FDA bladder cancer meeting","slug":"episode-502-aua-2026-and-fda-bladder-cancer-meeting","published_at":"2026-05-20T15:22:24+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-502-aua-2026-and-fda-bladder-cancer-meeting","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-502-AUA-2026-and-FDA-bladder-cancer-meeting-e3jlaf2","duration_seconds":2116,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-502-aua-2026-and-fda-bladder-cancer-meeting/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-502-aua-2026-and-fda-bladder-cancer-meeting.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 501: APCCC 2026 - Biochemically-relapsed Prostate cancer","slug":"episode-501-apccc-2026-biochemically-relapsed-prostate-cancer","published_at":"2026-05-18T13:55:21+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-501-apccc-2026-biochemically-relapsed-prostate-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-501-APCCC-2026---Biochemically-relapsed-Prostate-cancer-e3jhm17","duration_seconds":1179,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-501-apccc-2026-biochemically-relapsed-prostate-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-501-apccc-2026-biochemically-relapsed-prostate-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 500: RAS Inhibition in Pancreatic Cancer (yes this is the Uromigos podcast..)","slug":"episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast","published_at":"2026-05-11T17:46:58+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-500-RAS-Inhibition-in-Pancreatic-Cancer-yes-this-is-the-Uromigos-podcast-e3j7h0g","duration_seconds":2116,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-500-ras-inhibition-in-pancreatic-cancer-yes-this-is-the-uromigos-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 498: APCCC 2026 - mCRPC","slug":"episode-498-apccc-2026-mcrpc","published_at":"2026-05-02T04:31:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-498-apccc-2026-mcrpc","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-498-APCCC-2026---mCRPC-e3iojnl","duration_seconds":1290,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-498-apccc-2026-mcrpc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-498-apccc-2026-mcrpc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 497: Reflections on the capivasertib ODAC","slug":"episode-497-reflections-on-the-capivasertib-odac","published_at":"2026-05-01T21:52:50+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-497-reflections-on-the-capivasertib-odac","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-497-Reflections-on-the-capivasertib-ODAC-e3ip0uq","duration_seconds":1275,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-497-reflections-on-the-capivasertib-odac/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-497-reflections-on-the-capivasertib-odac.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 496: APCCC 2026 - mHSPC Landscape","slug":"episode-496-apccc-2026-mhspc-landscape","published_at":"2026-05-01T16:03:45+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-496-apccc-2026-mhspc-landscape","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-496-APCCC-2026---mHSPC-Landscape-e3iohg1","duration_seconds":1613,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-496-apccc-2026-mhspc-landscape/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-496-apccc-2026-mhspc-landscape.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 495: APCCC 2026 - Locally-advanced Prostate Cancer","slug":"episode-495-apccc-2026-locally-advanced-prostate-cancer","published_at":"2026-04-30T15:28:49+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-495-apccc-2026-locally-advanced-prostate-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-495-APCCC-2026---Locally-advanced-Prostate-Cancer-e3in1p7","duration_seconds":1866,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-495-apccc-2026-locally-advanced-prostate-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-495-apccc-2026-locally-advanced-prostate-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 494: Duration of EVP in Multiple Urothelial Cancer Settings / Paper of the Month PPARG Inverse Agonist","slug":"episode-494-duration-of-evp-in-multiple-urothelial-cancer-settings-paper-of-the-month-pparg-inverse-agonist","published_at":"2026-04-27T14:50:20+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-494-duration-of-evp-in-multiple-urothelial-cancer-settings-paper-of-the-month-pparg-inverse-agonist","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-494-Duration-of-EVP-in-Multiple-Urothelial-Cancer-Settings--Paper-of-the-Month-PPARG-Inverse-Agonist-e3ihlje","duration_seconds":2405,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-494-duration-of-evp-in-multiple-urothelial-cancer-settings-paper-of-the-month-pparg-inverse-agonist/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-494-duration-of-evp-in-multiple-urothelial-cancer-settings-paper-of-the-month-pparg-inverse-agonist.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 493: The Role of Chemotherapy in mHSPC","slug":"episode-493-the-role-of-chemotherapy-in-mhspc","published_at":"2026-04-13T10:00:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-493-the-role-of-chemotherapy-in-mhspc","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-493-The-Role-of-Chemotherapy-in-mHSPC-e3hke0d","duration_seconds":2843,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-493-the-role-of-chemotherapy-in-mhspc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-493-the-role-of-chemotherapy-in-mhspc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 492: Novel Biomarkers and Targets in Germ Cell Tumors","slug":"episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors","published_at":"2026-04-06T10:00:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-492-Novel-Biomarkers-and-Targets-in-Germ-Cell-Tumors-e3hb05a","duration_seconds":2005,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 490: Systemic Therapy Only in Patients wtih MIBC","slug":"episode-490-systemic-therapy-only-in-patients-wtih-mibc","published_at":"2026-03-30T10:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-490-systemic-therapy-only-in-patients-wtih-mibc","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-490-Systemic-Therapy-Only-in-Patients-wtih-MIBC-e3h4ffe","duration_seconds":2898,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-490-systemic-therapy-only-in-patients-wtih-mibc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-490-systemic-therapy-only-in-patients-wtih-mibc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 489: Live Podcast From EAU","slug":"episode-489-live-podcast-from-eau","published_at":"2026-03-16T11:37:02+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-489-live-podcast-from-eau","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-489-Live-Podcast-From-EAU-e3gguqg","duration_seconds":2898,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-489-live-podcast-from-eau/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-489-live-podcast-from-eau.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 487: ASCO GU 2026 recap","slug":"episode-487-asco-gu-2026-recap","published_at":"2026-03-08T18:45:03+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-487-asco-gu-2026-recap","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-487-ASCO-GU-2026-recap-e3g4fgn","duration_seconds":3370,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-487-asco-gu-2026-recap/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-487-asco-gu-2026-recap.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 486: ctDNA and utDNA Data in Peri-operative Urothelial cancer","slug":"episode-486-ctdna-and-utdna-data-in-peri-operative-urothelial-cancer","published_at":"2026-03-04T16:43:06+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-486-ctdna-and-utdna-data-in-peri-operative-urothelial-cancer","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-486-ctDNA-and-utDNA-Data-in-Peri-operative-Urothelial-cancer-e3fuc9b","duration_seconds":2732,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-486-ctdna-and-utdna-data-in-peri-operative-urothelial-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-486-ctdna-and-utdna-data-in-peri-operative-urothelial-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 485: ASCO GU 2026 - LITESPARK 011: Len/Belzu vs Cabo","slug":"episode-485-asco-gu-2026-litespark-011-len-belzu-vs-cabo","published_at":"2026-02-28T18:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-485-asco-gu-2026-litespark-011-len-belzu-vs-cabo","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-485-ASCO-GU-2026---LITESPARK-011-LenBelzu-vs-Cabo-e3fk2k7","duration_seconds":1887,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-485-asco-gu-2026-litespark-011-len-belzu-vs-cabo/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-485-asco-gu-2026-litespark-011-len-belzu-vs-cabo.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}